Pharmaceutical company Sanofi is planning to invest at least $20 billion in the United States until 2030, the company said in its announcement Wednesday. The company plans to expand its investment in science and expand domestic US manufacturing over the next few years.
“Sanofi’s 13,000 US-based employees are pioneering best-in-class drug research and development across numerous therapeutic areas. The expected investment in the US is substantial and will help ensure production of key drugs in the US.”
Sanofi is preparing the possibility of launching many new first-in-class medicines across many indications over the next few years, aiming to improve the health of countless Americans. Medicinal powers hope that this investment will unlock many jobs for Americans in certain communities and strengthen the US supply chain.
Additionally, Sanofi plans to expand its US manufacturing capacity along with US investment. This Komapuney accomplishes this by ensuring production of medicines in the US through direct investment in Sanofi Sites and partnerships with other domestic manufacturers.
